[Situation analysis of timing of first visit of anti-mitochondrial antibody-positive patients].

Rui Jin(Chinese Academy of Sciences), Bo Feng(Peking University), Haiyun Bai(China Datang Corporation (China)), Songlin Hong(China Datang Corporation (China)), Huiying Rao(Peking University), Jilian Fang, Xiaoxiao Wang(Peking University), Lihua Wang(Jiangxi University of Traditional Chinese Medicine), Qing Wang(New Hope Liuhe (China)), Hao Wang(Queen's University Belfast), Hui Ma(Fudan University), Lai Wei(Nanjing University of Finance and Economics)
PubMed
August 20, 2019
10.3760/cma.j.issn.1007-3418.2019.08.011
Cited by 3

Related Papers

Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers
|Nucleic Acids Research|2015|386
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2015|271
The mRNA related ceRNA–ceRNA landscape and significance across 20 major cancer types
|Nucleic Acids Research|2015|209
Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression To Suppress Colon Carcinoma Cell Invasion
|Molecular and Cellular Biology|2006|203
Anticancer Properties and Mechanisms of Fucoidan on Mouse Breast Cancer In Vitro and In Vivo
|PLoS ONE|2012|194